{
    "2021-03-22": [
        [
            {
                "time": "2021-03-01",
                "original_text": "Pfizer Outpaces Stock Market Gains: What You Should Know",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "stock market gains",
                        "outpaces"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "The FDA has ‘a lot of positive things to look at’ with AstraZeneca vaccine: Doctor",
                "features": {
                    "keywords": [
                        "FDA",
                        "AstraZeneca",
                        "vaccine",
                        "positive"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "Pfizer/Eli Lilly's Tanezumab Safety Profile Fails To Impress FDA Even After 15 Years Of Development Across 41 Trials",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Eli Lilly",
                        "Tanezumab",
                        "FDA",
                        "safety profile",
                        "fails"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "The vaccination news is promising in the U.S. and other parts of the world: Chief Strategist",
                "features": {
                    "keywords": [
                        "vaccination",
                        "promising",
                        "U.S.",
                        "world"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "There is a real threat that a new variant could arise and become dominant: Adjunct Assistant Prof. of Emergency Med.",
                "features": {
                    "keywords": [
                        "variant",
                        "threat",
                        "dominant"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "UPDATE 1-Swiss approve Johnson & Johnson COVID-19 vaccine, haven't bought any",
                "features": {
                    "keywords": [
                        "Swiss",
                        "approve",
                        "Johnson & Johnson",
                        "COVID-19 vaccine"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "U.S. on track to almost triple vaccine output in March, as new variants pressure Europe and Brazil",
                "features": {
                    "keywords": [
                        "U.S.",
                        "vaccine output",
                        "triple",
                        "variants",
                        "pressure"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "Lifted COVID-19 restrictions ‘defies logic’ at this point in recovery: Doctor",
                "features": {
                    "keywords": [
                        "COVID-19",
                        "restrictions",
                        "defies logic",
                        "recovery"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "AstraZeneca COVID-19 vaccine is 79% effective: U.S. study",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "COVID-19 vaccine",
                        "effective",
                        "study"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "UPDATE 2-Spain extends use of AstraZeneca vaccine to 18-65 year olds",
                "features": {
                    "keywords": [
                        "Spain",
                        "extends",
                        "AstraZeneca",
                        "vaccine",
                        "18-65 year olds"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "[video]Should You Buy AstraZeneca After Its Positive Vaccine News?",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "positive vaccine news",
                        "buy"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "Why I Didn't Jump on the Coronavirus Vaccine Stock Bandwagon",
                "features": {
                    "keywords": [
                        "Coronavirus",
                        "vaccine",
                        "stock",
                        "bandwagon"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "Got $5,000? Consider These 3 Leading Pharma Stocks",
                "features": {
                    "keywords": [
                        "$5,000",
                        "Pharma Stocks",
                        "consider"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "Malaysia sets up compensation fund for COVID-19 vaccinations",
                "features": {
                    "keywords": [
                        "Malaysia",
                        "compensation fund",
                        "COVID-19 vaccinations"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "Airfinity CEO on Vaccination Campaign",
                "features": {
                    "keywords": [
                        "Airfinity",
                        "CEO",
                        "Vaccination Campaign"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}